Jason Fleming, M.D., FACS

Dr. Fleming is a surgeon specializing in pancreatic cancer. He formerly served as Director of the Tissue Acquisition and Biorepository Core for the Pancreas Cancer Research Program at The University of Texas MD Anderson Cancer Center. Dr. Fleming initiated and developed the first direct xenograft program in GI cancer at The University of Texas MD Anderson Cancer Center. The xenografts are derived from human pancreatic adenocarcinomas that Dr. Fleming and his colleagues surgically remove from patients at The University of Texas MD Anderson Cancer Center. Direct xenografts recapitulate the tumor microenvironment and provide a unique platform to examine pancreatic adenocarcinoma.